NEOPROFEN
NDC 55292-122, ibuprofen lysine, solution, from Recordati Rare Diseases Inc..
- Product NDC
- 55292-122
- Status
- Listed
- Labeler
- Recordati Rare Diseases Inc.
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021903
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55292-122 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IBUPROFEN LYSINE10 mg/mL
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55292-122-52 | 55292012252 | 3 VIAL in 1 CARTON (55292-122-52) / 2 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6f5ede6f-b0b7-4fc8-969e-652f60ead047
Use it
Look up 55292-122 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55292-122 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55292-122. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.